Patients Treated (Revolade, Nplate, Doptelet, Tavlesse)
Dear Western Isles NHS Board,
I am requesting the following information on behalf of Novartis.
The purpose of these questions is to understand the variability of treatment within your trust and apply that to the context of the rest of the country.
Q1. How many patients has your trust treated (for any disease) in the last 6 months (or the latest 6 months data you have available) with the treatments listed below:
• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)
Q2. In the last 6 months (or the latest 6 months data you have available), how many patients has your trust treated for immune thrombocytopenia (ITP)?
Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last 6 months (or the latest 6 months data you have available), how many were treated with:
rituximab
mycophenolate mofetil
surgery (splenectomy)
Q4. Does your trust participate in any ongoing clinical trials for immune thrombocytopenia (ITP)? If so, can you please provide the name of each trial along with the number of patients taking part?
Thank you for taking the time to answer these questions and I look forward to your response.
Yours faithfully,
BEN HOLDSWORTH
Please accept this email as acknowledgement that NHS Western Isles has
received your FOI request below.
As per the Freedom of Information (Scotland) Act 2002, we will aim to meet
your request within 20 days from receiving it. In the eventuality of a
delay arising, I will contact you advising of this and the reason for it.
Regards,
Tina
NHS Western Isles / 37 South Beach Street / Stornoway / Isle of Lewis
/ HS1 2BB
[NHS Western Isles request email] / Tel: 01851 708031 / Fax: 01851 702036
══════════════════════════════════════════════════════════════════════════
From: BEN HOLDSWORTH <[FOI #889454 email]>
Sent: 22 August 2022 2:58 PM
To: WI FOI-Requests <[NHS Western Isles request email]>
Subject: Freedom of Information request - Patients Treated (Revolade,
Nplate, Doptelet, Tavlesse)
Dear Western Isles NHS Board,
I am requesting the following information on behalf of Novartis.
The purpose of these questions is to understand the variability of
treatment within your trust and apply that to the context of the rest of
the country.
Q1. How many patients has your trust treated (for any disease) in the last
6 months (or the latest 6 months data you have available) with the
treatments listed below:
• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)
Q2. In the last 6 months (or the latest 6 months data you have available),
how many patients has your trust treated for immune thrombocytopenia
(ITP)?
Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last
6 months (or the latest 6 months data you have available), how many were
treated with:
rituximab
mycophenolate mofetil
surgery (splenectomy)
Q4. Does your trust participate in any ongoing clinical trials for immune
thrombocytopenia (ITP)? If so, can you please provide the name of each
trial along with the number of patients taking part?
Thank you for taking the time to answer these questions and I look forward
to your response.
Yours faithfully,
BEN HOLDSWORTH
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #889454 email]
Is [NHS Western Isles request email] the wrong address for Freedom of Information
requests to Western Isles NHS Board? If so, please contact us using this
form:
[1]https://www.whatdotheyknow.com/change_re...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[2]https://www.whatdotheyknow.com/help/offi...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[3]https://www.whatdotheyknow.com/help/ico-...
[4]https://www.whatdotheyknow.com/help/ico-...
Please note that in some cases publication of requests and responses will
be delayed.
If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.
-------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
References
Visible links
1. https://www.whatdotheyknow.com/change_re...
2. https://www.whatdotheyknow.com/help/offi...
3. https://www.whatdotheyknow.com/help/ico-...
4. https://www.whatdotheyknow.com/help/ico-...
Please find attached NHS Western Isles response to your FOI request
below.
Regards,
Tina
NHS Western Isles / 37 South Beach Street / Stornoway / Isle of Lewis
/ HS1 2BB
[NHS Western Isles request email] / Tel: 01851 708031 / Fax: 01851 702036
══════════════════════════════════════════════════════════════════════════
From: BEN HOLDSWORTH <[FOI #889454 email]>
Sent: 22 August 2022 2:58 PM
To: WI FOI-Requests <[NHS Western Isles request email]>
Subject: Freedom of Information request - Patients Treated (Revolade,
Nplate, Doptelet, Tavlesse)
Dear Western Isles NHS Board,
I am requesting the following information on behalf of Novartis.
The purpose of these questions is to understand the variability of
treatment within your trust and apply that to the context of the rest of
the country.
Q1. How many patients has your trust treated (for any disease) in the last
6 months (or the latest 6 months data you have available) with the
treatments listed below:
• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)
Q2. In the last 6 months (or the latest 6 months data you have available),
how many patients has your trust treated for immune thrombocytopenia
(ITP)?
Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last
6 months (or the latest 6 months data you have available), how many were
treated with:
rituximab
mycophenolate mofetil
surgery (splenectomy)
Q4. Does your trust participate in any ongoing clinical trials for immune
thrombocytopenia (ITP)? If so, can you please provide the name of each
trial along with the number of patients taking part?
Thank you for taking the time to answer these questions and I look forward
to your response.
Yours faithfully,
BEN HOLDSWORTH
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #889454 email]
Is [NHS Western Isles request email] the wrong address for Freedom of Information
requests to Western Isles NHS Board? If so, please contact us using this
form:
[1]https://www.whatdotheyknow.com/change_re...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[2]https://www.whatdotheyknow.com/help/offi...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[3]https://www.whatdotheyknow.com/help/ico-...
[4]https://www.whatdotheyknow.com/help/ico-...
Please note that in some cases publication of requests and responses will
be delayed.
If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.
-------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
References
Visible links
1. https://www.whatdotheyknow.com/change_re...
2. https://www.whatdotheyknow.com/help/offi...
3. https://www.whatdotheyknow.com/help/ico-...
4. https://www.whatdotheyknow.com/help/ico-...
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now